Sector: Healthcare · Industry: Biotechnology
Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.
Headquarters: Waltham, MA · Employees: 145 · Website: https://www.kailera.com
CommScope Holding Company, Inc. (COMM) is a publicly traded company in the Healthcare sector (Biotechnology). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Macroplane tracks CommScope Holding Company, Inc.'s (COMM) supply chain. Key suppliers include APPLIED OPTOELECTRONICS, INC. (AAOI), Lumentum Holdings Inc. (LITE), W.W. GRAINGER, INC. (GWW), CORNING INC /NY (GLW), QUALCOMM INC/DE (QCOM), Liberty Global Ltd. (LBTYA), DYCOM INDUSTRIES INC (DY), SBA COMMUNICATIONS CORP (SBAC), and 17 more.
Competitors of CommScope Holding Company, Inc. (COMM) tracked by Macroplane include Broadcom Inc. (AVGO), Samsung Electronics Co., Ltd. (005930.KS), AMPHENOL CORP /DE/ (APH), Marvell Technology, Inc. (MRVL), ADVANCED MICRO DEVICES INC (AMD), INTEL CORP (INTC), Bharti Airtel Limited (BHARTIARTL.NS), MACOM Technology Solutions Holdings, Inc. (MTSI), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets